I'rom Group Co., Ltd. (2372.T) JPX

Currency In JPY

AD

I'rom Group Co., Ltd.

Address

Iidabashi Grand Bloom

Tokyo, 102-0071

Japan

Phone

81 3 3264 3148

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

1029

First IPO Date

February 01, 2005

Key Executives

NameTitlePayYear Born
Toyotaka MoriChief Executive Officer, President and Director01958
Zhu AfengExecutive Vice President & Director01957
Hiroaki InukaiSenior MD & Director01966
Shuichi KojimaSenior MD & Director01968
Kiyoshi WatanabeExecutive Vice President, Head of the Finance and Business Management & Director01958
Masaaki MatsushimaExecutive Vice President & Director01964
Yasutomo YamauchiHead of Legal Affairs Division, International HR Management Division & Director01971
Toshiya HaraExecutive Vice President of Sales & Director01970
AD

Description

I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.

AD